Sakuranetin-Functionalized Zinc Oxide Nanoparticles Inhibit Proliferation and Migration of Oral Squamous Cell Carcinoma Cells by Activating Mitochondrial Apoptosis
Year: 2026
Type: article
Abstract: Background Squamous cell carcinoma of the oral cavity is a very aggressive and poorly selectively treatable malignant tumour. The present study aimed to investigate the anticancer activity of sakuranetin (SKN)-functionalized zinc oxide nanoparticles (ZnO–SKN) in a human oral epidermoid carcinoma cell line (KB). Methods ZnO–SKN nanoparticles were synthesized and characterized by Fourier-transform infrared, XRD, and scanning electron microscope. Effects on cytotoxicity, intracellular reactive oxygen species (ROS), mitochondrial membrane potential, apoptosis, migration, colony formation, and apoptosis-related genes expression were evaluated by standard in vitro assays. Results Treatment with ZnO–SKN saw a reduction in viability of KB cells to 25% to 30% at 100 µg/mL, with at least 70% viable HOK cell population. It increased ROS levels, caused mitochondrial depolarization, and triggered apoptotic features, such as chromatin condensation and membrane blebbing. The colony formation was less than 20% inhibited, and the decrease in migration was 70% to 80%. The activation of the mitochondrial apoptotic pathway was confirmed by upregulation of CASP3 and BAX and downregulation of BCL2. Conclusion Overall, ZnO–SKN is a potential nanotherapeutic agent that can induce mitochondrial apoptosis by targeting ROS and not only inhibit the proliferation but also inhibit migration of oral cancer cells.
Source: International Dental Journal
Language: English
Subfield: Materials Chemistry
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $2,550
OpenAlex ID: W7226001569
